CURC

Carolina Urologic Research Center (CURC), under the direction of Dr. Neal Shore is a research arm of Grand Strand Urology in Myrtle Beach, SC

[ACRP - Assoc. of Clinical Research Profession @ACRPDC]

⚡On #ClinicalTrialsDay—the only global campaign dedicated to recognizing & championing #ClinicalResearch professionals—we celebrate YOU!

Watch this message of gratitude, tag your colleagues & share!

🎉 Our #CTD2025 Sponsors: @advarra @sanofi @thermofisher @velocitycr @Merck

[CURC @CURCMB]

Dr. @LaurenCooleyUro and clinical research coordinator, Ashley Burns RN, speak today at Duravelo-2 Investigator Meeting in Boston regarding their expertise on the phase 2/3 Duravelo-2/Bicycle Toxin clinical trial currently enrolling at Carolina Urologic Research Center

[CURC @CURCMB]

@LaurenCooleyUro and clinical research coordinator, Ashley Burns RN, speak today at Duravelo-2 Investigator Meeting in Boston regarding their expertise on the phase 2/3 Duravelo-2/Bicycle Toxin clinical trial currently enrolling at Carolina Urologic Research Center.

[CURC @CURCMB]

Dr. David Rich and Clinical Research Coordinator Ashley Burns attended training this weekend in Minneapolis for the new Vapor 2 Study from Francis Medical. CURC is excited to offer this focal therapy for intermediate risk prostate cancer soon! @AUCStoneGuy @FrancisMedical

[CURC @CURCMB]

@BladderCancerUS #bladderwalk #walktoendbladdercancer #noonewalksalone @shekabhishek

[CURC @CURCMB]

Dr. Abhi @shekabhishek and Dr. Shore walking today with our CURC team in the BCAN Walk to End Bladder Cancer. We are honored to walk for our patients! @BladderCancerUS #bladderwalk #noonewalksalone

[CURC @CURCMB]

CURC was proud to sponsor the Zero Prostate Cancer Tee Off event at Top Golf and help to raise $31,000 to zero out prostate cancer!

[OncLive.com @OncLive]

Extended Darolutamide Demonstrates Long-term Safety, Clinical Benefit in Nonmetastatic CRPC @CURCMB @AmerUrological #AUA23 #pcsm https://t.co/Oo8dkBZFoS

[Ed Esplin, MD, PhD @EdEsplin]

Two of the Most Read Articles of 2022:
(#3) @tumastologo1 et al. w/ @Invitae https://t.co/08TMYWn706 @JCOGO_ASCO
&
(#5) Esplin et al. w/ @DanaFarber @cityofhope @MayoClinic @CURCMB @Invitae https://t.co/Pm2rUkQF2m @JCOPO_ASCO
#patient #access #universal #germlinetesting

[Ed Esplin, MD, PhD @EdEsplin]

PROCLAIM...supports #universal #genetictesting for #prostatecancer #patients [to] eliminate barriers to #precisiontherapy, optimize #patient outcomes & accelerate equitable access to care - #DrNealShore @CURCMB

https://t.co/InzCoNR5ei

https://t.co/Pm2rUkQF2m @JCOPO_ASCO @ASCO

[Ed Esplin, MD, PhD @EdEsplin]

"#Universal #Germline #GeneticTesting for Hereditary Cancer Syndromes in #Patients With Solid Tumor #Cancer"

@judygarber5 @DrHQRana @DanaFarber @HHampel1 @cityofhope @J_Samadder @MayoClinic #DrNealShore @CURCMB @Invitae in @JCOPO_ASCO @ASCO

https://t.co/gKD8dVL1ol

[Bladder Cancer Advocacy Network @BladderCancerUS]

In case you have missed #BCANTT22, @pjhensley11 has some wonderful summaries of some of the sessions at the conference. Click here to read them: https://t.co/jHmRLIgJAG #bladdercancer

[Omar Alhalabi, MD @OAlhalabiMD]

.@BenMironMD @FoxChaseCancer brainstorming how to integrate urine and blood ctDNA into improving trials that help patients with localized #bladdercancer retain their bladder yet still be cured. One of the best highlights of this thinktank #BCANTT22!

[CURC @CURCMB]

Can’t wait for next year!

[Dr. Bishoy M. Faltas @FaltasLab]

It was great to see everyone at #BCANTT22, looking forward to welcoming you all #BCANTT23 in DC @BladderCancerUS

[Wesley Yip @WesleyYipMD]

Final session of #BCANTT22. What makes this meeting special is the star-studded panel that includes a #PatientAdvocate, and the discussion starts and ends with the patient voice.

Thank you for an amazing meeting @BladderCancerUS!

[CURC @CURCMB]

This was a great panel and end to #BCANTT22. Our site currently offers 2 bladder-soaring trials for MIBC. Very interesting to hear more insight and research on this topic!

[Bladder Cancer Advocacy Network @BladderCancerUS]

#BCANTT22 panel on Organ-Sparing Management for Muscle-Invasive #Bladdercancer with ⁦@BenMironMD⁩

[CURC @CURCMB]

#BCANTT22

[CURC @CURCMB]

Medical Director/Principal Investigator Dr. Neal Shore and RN/Clinical Research Coordinator Ashley Burns of CURC attending the #BCANTT22 conference

[Bladder Cancer Advocacy Network @BladderCancerUS]

Today at #BCANTT22, BCAN announced its first-ever Translational Clinical Trial Award (TCTA) to support patient-oriented research to transform #bladdercancer - up to $3M in funding over 3 years. Click for more detailed about this exciting announcement: https://t.co/t6MTgALguB

[CURC @CURCMB]

Really enjoyed this discussion on the sequencing of therapies for Metastatic UC. Great insight from the presenters and attendees.

[Shilpa Gupta @shilpaonc]

Happening now! @kalasri3 kicking off our session on Sequencing therapies sun mUC #BCANTT22 @BladderCancerUS

@bcan_chisolm@PGrivasMDPhD @DrOmarMian @ERPlimackMD

Lot of interesting discussion about cisplatin, platinum ineligibility, sequencing, biomarkers and case discussion!